Persistent inadequate disease control and therapeutic inertia in moderate-to-severe atopic dermatitis: a 12-month longitudinal analysis of real-world outcomes from TARGET-DERM registry.

MLA

Eichenfield, Lawrence F., et al. “Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Analysis of Real-World Outcomes from TARGET-DERM Registry.” British Journal of Dermatology, vol. 190, Feb. 2024, pp. ii60-ii61. EBSCOhost, https://doi.org/10.1093/bjd/ljad498.063.

APA

Eichenfield, L. F., Grada, A., Knapp, K. D., Munoz, B., Crawford, J. M., & Silverberg, J. I. (2024). Persistent inadequate disease control and therapeutic inertia in moderate-to-severe atopic dermatitis: a 12-month longitudinal analysis of real-world outcomes from TARGET-DERM registry. British Journal of Dermatology, 190, ii60-ii61. https://doi.org/10.1093/bjd/ljad498.063

Chicago

Eichenfield, Lawrence F., Ayman Grada, Keith D. Knapp, Breda Munoz, Julie M. Crawford, and Jonathan I. Silverberg. 2024. “Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Analysis of Real-World Outcomes from TARGET-DERM Registry.” British Journal of Dermatology 190 (February): ii60-ii61. doi:10.1093/bjd/ljad498.063.